Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial

被引:39
|
作者
Wanlapakorn, Nasamon [1 ,2 ]
Maertens, Kirsten [3 ]
Vongpunsawad, Sompong [1 ]
Puenpa, Jiratchaya [1 ]
Thao Mai Phuong Tran [4 ]
Hens, Niel [4 ,5 ]
Van Damme, Pierre [3 ]
Thiriard, Anais [6 ]
Raze, Dominique [6 ]
Locht, Camille [6 ]
Poovorawan, Yong [1 ]
Leuridan, Elke [3 ]
机构
[1] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand
[2] Chulalongkorn Univ, Div Acad Affairs, Fac Med, Bangkok, Thailand
[3] Univ Antwerp, Fac Med & Hlth Sci, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Univ Pl 1, B-2610 Antwerp, Belgium
[4] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium
[5] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium
[6] Univ Lille, Ctr Hosp Reg Univ Lille, CNRS,Inst Pasteur Lille, Ctr Infect & Immun Lille,U1019 UMR8204,INSERM, Lille, France
基金
欧洲研究理事会;
关键词
pertussis; pregnancy; maternal immunization; humoral immune response; functionality; PRIMARY IMMUNIZATION; IMMUNE-RESPONSES; IMMUNOGENICITY; TDAP; IMPACT; WOMEN;
D O I
10.1093/cid/ciz778
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The blunting effect of pertussis immunization during pregnancy on infant antibody responses induced by whole-cell pertussis (wP) vaccination is not well-defined. Methods. This randomized controlled trial (NCT02408926) followed term infants born to mothers vaccinated with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine during pregnancy in Thailand. Infants received either acellular pertussis (aP)- or wP-containing vaccine at 2, 4, 6, and 18 months of age. A comparison group comprised wP-vaccinated children born to mothers not vaccinated during pregnancy. Antibodies against pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) were evaluated using commercial enzyme-linked immunosorbent assays. Functionality of antibodies against Bordetella pertussis was measured using Bordetella pertussis growth inhibition assay. Results. After maternal Tdap vaccination, 158 infants vaccinated with aP-containing vaccines possessed higher antibody levels (P < .001) against all tested B. pertussis antigens postpriming compared to 157 infants receiving wP-containing vaccines. At 1 month postbooster, only anti-FHA and anti-PRN antibodies were still significantly higher (P < .001) in the aP group. Significantly higher anti-PT and anti-FHA (P < .001), but not anti-PRN immunoglobulin G, were observed among 69 wP-vaccinated infants born to control mothers compared with wP-vaccinated infants of Tdap-vaccinated mothers after primary and booster vaccination. The antibody functionality was higher in all wP-vaccinated infants at all times. Conclusions. Maternal Tdap vaccination inhibited more pertussis-specific responses in wP-vaccinated infants compared to aP-vaccinated infants, and the control group of unvaccinated women had highest PT-specific responses, persisting until after the booster dose. Antibody functionality was better in the wP groups.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 50 条
  • [21] Relationship between structure and neutralizing activity of rabbit tetanus antibodies elicited by acellular and whole-cell pertussis DTP vaccines
    Dokmetjian, J
    Della Valle, C
    Lavigne, V
    Eriksson, PV
    Manghi, MA
    VACCINE, 1998, 16 (07) : 672 - 677
  • [22] A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response
    Halperin, Scott A.
    Langley, Joanne M.
    Ye, Lingyun
    MacKinnon-Cameron, Donna
    Elsherif, May
    Allen, Victoria M.
    Smith, Bruce
    Halperin, Beth A.
    McNeil, Shelly A.
    Vanderkooi, Otto G.
    Dwinnell, Shannon
    Wilson, R. Douglas
    Tapiero, Bruce
    Boucher, Marc
    Le Saux, Nicole
    Gruslin, Andree
    Vaudry, Wendy
    Chandra, Sue
    Dobson, Simon
    Money, Deborah
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (07) : 1063 - 1071
  • [23] Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial (vol 311, pg 1760, 2014)
    Munoz, F. M.
    Bond, N. H.
    Maccato, M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 442 - 442
  • [24] Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
    Knuutila, Aapo
    Barkoff, Alex-Mikael
    Ivaska, Lauri
    Tenhu, Elina
    Terasjarvi, Johanna
    van Gageldonk, Pieter
    Buisman, Annemarie
    Mertsola, Jussi
    He, Qiushui
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [25] Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination
    Embacher, Stefan
    Maertens, Kirsten
    Herzog, Sereina A.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (11): : 1640 - 1648
  • [26] Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine
    Dagan, R
    Igbaria, K
    Piglansky, L
    Melamed, R
    Willems, P
    Grossi, A
    Kaufhold, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (12) : 1113 - 1121
  • [27] Safety of three acellular pertussis vaccines and one whole-cell vaccine in a Swedish multi-centre trial.
    Rasmussen, F
    Heijbel, H
    Olin, P
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 149 - 149
  • [28] THE EFFECT OF MATERNAL ANTIBODY ON THE SEROLOGIC RESPONSE AND THE INCIDENCE OF ADVERSE REACTIONS AFTER PRIMARY IMMUNIZATION WITH ACELLULAR AND WHOLE-CELL PERTUSSIS VACCINES COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS
    ENGLUND, JA
    ANDERSON, EL
    REED, GF
    DECKER, MD
    EDWARDS, KM
    PICHICHERO, ME
    STEINHOFF, MC
    RENNELS, MB
    DEFOREST, A
    MEADE, BD
    PEDIATRICS, 1995, 96 (03) : 580 - 584
  • [29] A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine
    Stehr, K
    Cherry, JD
    Heininger, U
    Schmitt-Grohe, S
    Uberall, M
    Laussucq, S
    Eckhardt, T
    Meyer, M
    Engelhardt, R
    Christenson, P
    PEDIATRICS, 1998, 101 (01) : 1 - 11
  • [30] A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine In Senegal
    Simondon, F
    Preziosi, MP
    Yam, A
    Kane, CT
    Chabirand, L
    Iteman, I
    Sanden, G
    Mboup, S
    Hoffenbach, A
    Knudsen, K
    Guiso, N
    Wassilak, S
    Cadoz, M
    VACCINE, 1997, 15 (15) : 1606 - 1612